Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Infectious Disease
Open-data reference.
19 US clinical trials · 8 currently recruiting
Active & Recent Trials
AnovaOS Network Powered Patient Registry
Anova Enterprises
NCT05013944
Collection and Distribution of Biospecimens for Novel Research Uses
iSpecimen
NCT03848962
Triage Survey for Infectious Disease Eligibility
Brooklyn Clinical Research
NCT06492187
Compliant Analysis of Patient Samples and Data
Sequenom
NCT04364503
An International Observational Study of Adults With Acute Infection
University of Minnesota
NCT07069400
Antibiotics for Delirium in Older Adults With No Clear Urinary Tract Infection
Mount Sinai Hospital, Canada
NCT06004739
Pharmacogenomics for Better Treatment of Fungal Infections in Cancer
The University of Queensland
NCT06510699
Ocular Pathogen and Transcriptome Investigation Using Comprehensive Sequencing
University of California, San Francis
NCT05286203
Addressing Risk Through Community Treatment for Infectious Disease and Opioid Use Disorder Now (ACTION) Among Justice-involved Populations
Yale University
NCT05286879
A Phase 1 Study to Evaluate JCXH-108, an mRNA-based Vaccine Against RSV
Immorna Biotherapeutics
NCT06564194
A Validation Study of the Lab Clasp Device: A Point of Care Sepsis Risk Monitor
Brigham and Women's Hospital
NCT04796285
Minnesota COVID-19 Testing Project
Harvard University
NCT04568889
University of Utah COVID-19 Hydrochloroquine Trial
University of Utah
NCT04342169
Clinical Decision Support Tools for Antibiotic Prescribing
Beth Israel Deaconess Medical Center
NCT03580603
Incisional Negative Pressure Wound Therapy for Preoperatively Irradiated Lower Extremity Soft Tissue Sarcoma Wounds
Medical University of South Carolina
NCT02638298
A First-in-Human Study to Evaluate JCXH-105, an SrRNA-based Herpes Zoster Vaccine
Immorna Biotherapeutics
NCT05871541
Reduction of Staph Aureus Carriage by Non-Antibiotic NOZIN® Nasal Sanitizer® Antiseptic
Medical University of South Carolina
NCT01861457
Performance of a Remote Monitoring Program for Patients Diagnosed With COVID-19
George Washington University
NCT05063812
Implementation of CareCube Negative Pressure Isolation Units
Saint Luke's Health System
NCT05229926
Phase Distribution
| Phase | Trial count |
|---|---|
| Early Phase 1 | 2 |
| Phase 2 | 2 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the Infectious Disease Trial Landscape
ClinicalTrials.gov lists 19 US studies indexed under Infectious Disease, and 8 of those are currently open to recruitment — roughly 42% of the total volume on the registry. That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
The phase distribution for Infectious Disease shows 0 late-stage studies (Phase 3 and Phase 4 combined) alongside 4 earlier-phase entries (Phase 1 through Phase 2). Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
Top sponsor activity for Infectious Disease is led by Immorna Biotherapeutics with 2 indexed trials, alongside 9 other organizations in the top contributor list. The list on this page surfaces up to 19 of the most relevant recent and active entries, ordered with recruiting studies first so practical options are visible. All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation — eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for Infectious Disease?
PlainTrial tracks 19 US clinical trials for Infectious Disease, of which 8 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for Infectious Disease?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology — how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2024 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.